Meril is a global medical device company operating in more than 100 countries. It is dedicated towards design and development of novel, clinically relevant, state-of-the-art and best-in-class devices to alleviate human suffering and improve the quality of life. Operating across broad operational canvas from vascular interventional devices to orthopedics, endo-surgery and in-vitro diagnostics, the company has a strong commitment towards R & D and adherence to best quality standards and technology. With the CDSCO approval, Meril is the first Indian company to have indigenously developed the Transcatheter Aortic Heart Valve Replacement Therapy available for patients.
CORE OBJECTIVE
To develop, manufacture & distribute clinically relevant, state-of-the-art & best-in-the-class products to alleviate human suffering & improve quality of life
Meril was born with the aim of improving the quality of human life through innovative and advanced healthcare solutions.
As a medical device manufacturer, we exist to improve the inventiveness in healthcare so that people’s lives are enriched.
We continually seek excellence in providing answers to some of medicine’s toughest questions.
World Class Infrastructure
Robust R&D, Ultra-modern, Large Manufacturing & Commitment to Clinical Research
Large, Hi-Tech, Ultra modern manufacturing facility
Dedicated R&D Complex with over 150 R&D professionals
Dedicated studies with over 15,000 patients in clinical research globally
Accreditation’s from major FDA bodies
CDSCO, CE, USFDA, NMPA, KFDA, ANVISA, INVIMA, Russia MoH, TGA, Canada, PMDA Japan
Meril Academy
Meril Academy is committed to Training & Education
Over 10,000 Healthcare Professionals trained across therapies like vascular interventional, orthopedics, endo-surgery and structural heart. Meril Academy is world class training institute with OT simulation area, web streaming facility, international faculty collaborations and large class-rooms for didactic lectures. Academy will be conducting dedicated TAVR training program regularly, if interested Contact Us.